E21.3
Hyperparathyroidism, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
Hyperparathyroidism is a condition characterized by the overproduction of parathyroid hormone (PTH) by the parathyroid glands, which are four small glands located in the neck near the thyroid. When these glands produce too much PTH, it can lead to disruptions in calcium and phosphate levels in the body, resulting in various health issues. The term 'unspecified' indicates that the specific type of hyperparathyroidism has not been identified or detailed. This condition can develop gradually and may be asymptomatic initially, but it can cause significant health problems if left untreated.
Causes & Symptoms
Clinical Causes: Primary hyperparathyroidism, often caused by a benign tumor (adenoma) on one of the parathyroid glands. Secondary hyperparathyroidism, commonly due to chronic kidney disease or vitamin D deficiency leading to low calcium levels, prompting increased PTH production. Tertiary hyperparathyroidism, which may develop in patients with longstanding secondary hyperparathyroidism, especially after kidney transplantation. Genetic syndromes or familial disorders that predispose individuals to hyperparathyroidism. Radiation exposure to the neck area. Certain medications that affect calcium and PTH levels.
Key Symptoms: Muscle weakness Fatigue Bone pain and fragility fractures Kidney stones Abdominal pain, nausea, and vomiting Constipation Psychological disturbances such as depression or confusion Excessive urination (polyuria) and increased thirst Poor appetite Elevated blood calcium levels (hypercalcemia)
Diagnostic & Treatment
Diagnosis Path: Diagnosis of hyperparathyroidism typically involves blood tests to measure calcium and PTH levels. Elevated calcium combined with high or inappropriately normal PTH levels suggests hyperparathyroidism. Additional tests may include:
Treatment Protocols: Treatment options for hyperparathyroidism depend on the severity and underlying cause. Management strategies include:
Clinical Advice & FAQs
Billing Guidance
Is E21.3 a billable ICD-10 code?
Yes, E21.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E21.3?
Clinical documentation must specify the nature of Hyperparathyroidism, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference